DarioHealth Corp. (DRIO) Stock Score, Valuation & Financial Research
DarioHealth Corp. is in the Healthcare sector and Medical - Specialties industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 34/100.
Quick answer for DRIO
DarioHealth Corp. currently has a Wall Street Score of 34/100. The stored market price is $6.93. Its financial score is 12/100. Its valuation score is 26/100. These figures are a research snapshot, not a buy or sell recommendation.
What DarioHealth Corp. does
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care. Their offerings extend to general chronic condition management solutions and DarioEngage, a proprietary care management platform. In terms of hardware, DarioHealth provides smart glucose meters, Bluetooth-connected blood pressure cuffs, digital scales, biofeedback sensor devices, and disposables such as test strip cartridges and lancets for blood glucose monitoring systems. Furthermore, they off
DRIO financial snapshot
- Wall Street Score:
- 34/100
- Current price:
- $6.93
- Market capitalization:
- $50.7M
- Revenue:
- $21.0M
- Net income:
- $67.8M
- Free cash flow:
- $-26.1M
- Cash:
- $6.6M
- Total debt:
- $32.4M
- EPS:
- 0.69
- P/E ratio:
- 10.0x
- Financial score:
- 12/100
- Valuation score:
- 26/100
- Revenue score:
- 43/100
What stands out
- Reported year-over-year revenue growth is -0.1%.
- Free cash flow is $-26.1M, showing cash burn in the current stored period.
- The balance sheet shows $6.6M of cash versus $32.4M of total debt, so leverage deserves attention.
- The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.
What the numbers mean
Its current valuation score is 26/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 12/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-06.
How to research DRIO
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.